CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Catalyst Pharmaceuticals, Inc.

For profitContributed to NMEWebsite ↗

Also known as: Catalyst Pharmaceuticals, Inc. | CATALYST PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 1, 2007

First marketed drug

Oct 22, 2012

First NDA

Nov 28, 2018

Last known activity

Mar 7, 2019

Timeline

2000s

  1. Jul 2, 2002

    Catalyst Pharmaceuticals, Inc.— Founded

2010s

  1. Oct 22, 2012

    perampanel— Marketing Organization

  2. Oct 22, 2012

    perampanel— NDA Secondary Org

  3. Nov 28, 2018

    amifampridine phosphate— NDA Organization

Drugs by trial phase (3 distinct, 13 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (3)

Recent trials (14)

Details

Founded
Coral Gables, FL, US Jul 2, 2002
First NDA
Nov 28, 2018
Last known activity
Mar 7, 2019

Designations held

  • Orphan drug
  • Priority review
  • Breakthrough therapy